CompletedNot Applicable

Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic

Spain89 participantsStarted 2017-12-18

Plain-language summary

The main purpose of this study is to evaluate a therapy for the inflammaging (premature aging).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older than 18 years old. * Documented HIV-1 infection. * Be in treatment with these antiretrovirals (INI, IP, ITINAN) during 12 months. * HIV-1 Viral titer \<50 copies/mL during 6 months. * CD4\> 500 cells/mm3. Exclusion Criteria: * Treatment with antibiotics. * Severe diseases actives. * Defining diseases of AIDS in the previous year. * Gut surgery except appendectomy or cholecystectomy. * Pregnancy. * Any diet deviation (vegans). * Other probiotic treatment.

What they're measuring

The appearance of adverse effects.

Timeframe: Change from Baseline Adverse Effects will be measured at 1 month and 3 months after the treatment beginning (V1 and V2 respectively).

Trial details

NCT IDNCT03542786

SponsorAB Biotics, SA

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2020-02-29

View on ClinicalTrials.gov More HIV trials